Long-term retention rate of entacapone in the treatment of Parkinson's disease.
Keränen
T
T
Tuhkasaari
M
M
Kuusisto
H
H
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D002396:Catechols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D009570:Nitriles / Q000627:therapeutic use*; D020734:Parkinsonian Disorders / Q000188:drug therapy*; D016016:Proportional Hazards Models; D012189:Retrospective Studies
D000978:Antiparkinson Agents; D002396:Catechols; D009570:Nitriles; C071192:entacapone